Ultragenyx Pharmaceutical Inc. - COM (RARE)

Q2 2024 13F Holders as of 6/30/2024

Type / Class
Equity / COM
Number of holders
270
Total Shares
88.2M
Shares change
+9.17M
Total reported value, excl. options
$3.62B
Value change
+$371M
Put/Call ratio
0.43
Number of buys
160
Number of sells
-117
Price
$41.10
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.